BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11974889)

  • 1. [Neutralizing activity of human immunoglobulin preparation against toxic shock syndrome toxin-1].
    Nakae T; Hirayama F; Hashimoto M
    Kansenshogaku Zasshi; 2002 Mar; 76(3):195-202. PubMed ID: 11974889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
    Feng MH; Cui JC; Nakane A; Hu DL
    Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin.
    Yanagisawa C; Hanaki H; Natae T; Sunakawa K
    J Infect Chemother; 2007 Dec; 13(6):368-72. PubMed ID: 18095084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
    Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
    Bonventre PF; Heeg H; Cullen C; Lian CJ
    Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
    Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
    Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.
    Bonventre PF; Thompson MR; Adinolfi LE; Gillis ZA; Parsonnet J
    Infect Immun; 1988 Jan; 56(1):135-41. PubMed ID: 3257201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
    Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
    J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.
    Scott DF; Kling JM; Best GK
    Infect Immun; 1986 Aug; 53(2):441-4. PubMed ID: 3733224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgM antibodies to toxic shock syndrome toxin-1 in human sera and human immunoglobulins].
    Dickgiesser N; Düzgün F
    Klin Wochenschr; 1988 Jan; 66(1):7-11. PubMed ID: 3343806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.
    Saha B; Jaklic B; Harlan DM; Gray GS; June CH; Abe R
    J Immunol; 1996 Nov; 157(9):3869-75. PubMed ID: 8892617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.
    Reeves MW; Arko RJ; Chandler FW; Bridges NB
    Infect Immun; 1986 Feb; 51(2):431-9. PubMed ID: 3943896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody.
    Best GK; Scott DF; Kling JM; Thompson MR; Adinolfi LE; Bonventre PF
    Infect Immun; 1988 Apr; 56(4):998-9. PubMed ID: 3346079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Level of TSST-1 Antibody in Burn Patients With Toxic Shock Syndrome Caused by Methicillin-Resistant Staphylococcus aureus.
    Matsushima A; Kuroki Y; Nakajima S; Sakai T; Kojima H; Ueyama M
    J Burn Care Res; 2015; 36(3):e120-4. PubMed ID: 25094005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
    Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
    Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children.
    Quan L; Morita R; Kawakami S
    Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.
    Stach CS; Vu BG; Merriman JA; Herrera A; Cahill MP; Schlievert PM; Salgado-Pabón W
    PLoS One; 2016; 11(4):e0154762. PubMed ID: 27124393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1.
    Scott DF; Best GK; Kling JM; Thompson MR; Adinolfi LE; Bonventre PF
    Rev Infect Dis; 1989; 11 Suppl 1():S214-7; discussion S217-8. PubMed ID: 2928638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.